Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial

被引:13
|
作者
van Balkom, Tim D. [1 ,2 ]
Berendse, Henk W. [3 ]
van der Werf, Ysbrand D. [2 ]
Twisk, Jos W. R. [4 ]
Peeters, Carel F. W. [5 ]
Hoogendoorn, Adriaan W. [6 ]
Hagen, Rob H. [7 ]
Berk, Tanja [7 ]
van den Heuvel, Odile A. [1 ,2 ]
Vriend, Chris [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Neurosci, Anat & Neurosci, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam Neurosci, Neurol, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam Publ Hlth, Epidemiol & Biostat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[5] Wageningen Univ & Res, Math & Stat Methods Grp Biometris, POB 16, NL-6700 AA Wageningen, Netherlands
[6] GGZ InGeest, Res & Innovat, Oldenaller 1, NL-1081 HL Amsterdam, Netherlands
[7] Dutch Parkinsons Dis Assoc, POB 46, NL-3980 CA Bunnik, Netherlands
关键词
Parkinson's disease; Cognitive training; RCT; Cognitive impairment; Dementia; Cognitive rehabilitation; DIAGNOSTIC-CRITERIA; IMPAIRMENT; DISORDER; DECLINE; BRAIN;
D O I
10.1016/j.parkreldis.2022.02.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Cognitive training (CT) has been proposed as a treatment option for cognitive impairment in Parkinson's disease (PD). We aimed to assess the efficacy of adaptive, computerized CT on cognitive function in PD. Methods: In this double-blind, randomized controlled trial we enrolled PD patients that experienced substantial subjective cognitive complaints. Over a period of eight weeks, participants underwent 24 sessions of computerized multi-domain CT or an active control intervention for 45 min each (randomized 1:1). The primary outcome was the accuracy on the Tower of London task; secondary outcomes included effects on other neuropsychological outcomes and subjective cognitive complaints. Outcomes were assessed before and after training and at six-months follow-up, and analyzed with multivariate mixed-model analyses. Results: The intention-to-treat population consisted of 136 participants (n = 68 vs. n = 68, age M: 62.9y, female: 39.7%). Multivariate mixed-model analyses showed no group difference on the Tower of London accuracy corrected for baseline performance (n = 130): B: 0.06, 95% CI: 0.27 to 0.15, p = 0.562. Participants in the CT group were on average 0.30 SD (i.e., 1.5 s) faster on difficulty load 4 of this task (secondary outcome): 95% CI: 0.55 to 0.06, p = 0.015. CT did not reduce subjective cognitive complaints. At follow-up, no group differences were found. Conclusions: This study shows no beneficial effect of eight-week computerized CT on the primary outcome (i.e., planning accuracy) and only minor improvements on secondary outcomes (i.e., processing speed) with limited clinical impact. Personalized or ecologically valid multi-modal intervention methods could be considered to achieve clinically meaningful and lasting effects.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [41] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
  • [42] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [43] Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
    Asako Yoritaka
    Yasuko Kobayashi
    Tetsuo Hayashi
    Shinji Saiki
    Nobutaka Hattori
    Neurological Sciences, 2021, 42 : 4767 - 4770
  • [44] A randomized, double-blind, controlled trial of add-on therapy in moderate-to-severe Parkinson's disease
    Zhao, Shifu
    Cheng, Rongchuan
    Zheng, Jian
    Li, Qianning
    Wang, Jingzhou
    Fan, Wenhui
    Zhang, Lili
    Zhang, Yanling
    Li, Hongzeng
    Liu, Shuxiao
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (10) : 1214 - 1218
  • [45] Pingchan granule for depressive symptoms in parkinson's disease:A randomized, double-blind, placebo-controlled trial
    Si-chun Gu
    Jie Zhou
    Qing Ye
    Can-xing Yuan
    Journal of Integrative Medicine, 2021, 19 (02) : 120 - 128
  • [46] Reprogramming of updated neurostimulators in chronically implanted patients with Parkinson's disease: A double-blind randomized controlled trial
    Boogers, Alexandra
    Justich, Maria Belen
    Montiel, Marcela
    Alhashyan, Ibrahim
    Naghdlou, Sara
    Sumarac, Srdjan
    Milosevic, Luka
    Lozano, Andres M.
    Kalia, Suneil K.
    Munhoz, Renato P.
    Fasano, Alfonso
    BRAIN STIMULATION, 2025, 18 (01) : 138 - 140
  • [47] Transdermal Rotigotine in Early Stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Trial
    Mizuno, Yoshikuni
    Nomoto, Masahiro
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (10) : 1447 - 1450
  • [48] Pingchan granule for depressive symptoms in parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Gu, Si-chun
    Zhou, Jie
    Ye, Qing
    Yuan, Can-xing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 120 - 128
  • [49] Commentary: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial
    Leblhuber, Friedrich
    Egger, Michael
    Schuetz, Burkhard
    Fuchs, Dietmar
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [50] A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease
    Rascol, Olivier
    Medori, Rossella
    Baayen, Corine
    Such, Pedro
    Meulien, Didier
    MOVEMENT DISORDERS, 2022, 37 (05) : 1088 - 1093